 |
|
Home | ImmunoGen Downgraded by Oppenheimer (IMGN) |
 |
ImmunoGen Downgraded by Oppenheimer (IMGN)
|
 |
- January 28, 2013
-
ImmunoGen (NASDAQ: IMGN) was downgraded by equities research analysts at Oppenheimer from an “outperform” rating to a “perform” rating in a research note issued to investors on Monday. They currently have a $14.00 price target on the stock. Several other analysts have also recently commented on the stock. Analysts at Morgan Stanley initiated coverage on [...]This article (ImmunoGen Downgraded by Oppenheimer (IMGN)) was originally developed by and is property of American Banking News. Checkout American Banking News for up-to-date banking news and peer to peer lending news.
- Read more at:http://www.americanbankingnews.com/2013/01/28/immunogen-downgraded-by-oppenheimer-imgn/
|
 |
|
 |
|
 |
